These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6165867)

  • 1. Current report on the interferon program at Roswell Park Memorial Institute.
    Murphy GP
    J Surg Oncol; 1981; 17(2):99-111. PubMed ID: 6165867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human interferon and its inducers: clinical program overview at Roswell Park Memorial Institute.
    Carter WA; Horoszewicz JS
    Cancer Treat Rep; 1978 Nov; 62(11):1897-8. PubMed ID: 728908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
    Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
    Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.
    Zarling JM; Sosman J; Eskra L; Borden EC; Horoszewicz JS; Carter WA
    J Immunol; 1978 Nov; 121(5):2002-4. PubMed ID: 309487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effect of human fibroblast interferon on malignant cancer. (2) Immunological study of the patients under treatment].
    Ezaki K; Okabe K; Domyo M; Abe K; Ogawa M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):238-43. PubMed ID: 7184400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effect of interferon in malignant brain tumours.
    Nagai M; Arai T
    Neurosurg Rev; 1984; 7(1):55-64. PubMed ID: 6379511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes.
    Isacsohn M; Berson B; Sternberg I; Morag A
    Isr J Med Sci; 1983 Nov; 19(11):959-62. PubMed ID: 6319325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.
    Kataoka T; Sakurai Y; Ida N; Kobayashi S
    Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical application of fibroblast interferon--an overview.
    Billiau A
    Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human fibroblast interferon on the cytotoxic activity of natural killer cells and lymphocytes against autochthonous and allogeneic tumor cells.
    Ezaki K; Okabe K; Domyo M; Abe K; Kubokawa C; Ogawa M
    Gan; 1983 Oct; 74(5):723-9. PubMed ID: 6227516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human interferons: an overview.
    Mizrahi A
    Dev Biol Stand; 1983; 55():219-30. PubMed ID: 6203796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLINICOPATHOLOGIC Conference, Roswell Park Memorial Institute, Buffalo, New York.
    N Y State J Med; 1959 Dec; 59():4589-94. PubMed ID: 13857929
    [No Abstract]   [Full Text] [Related]  

  • 14. American cancer society Phase I trial of naturally produced beta-interferon.
    Hawkins MJ; Krown SE; Borden EC; Krim M; Real FX; Edwards BS; Anderson SA; Cunningham-Rundles S; Oettgen HF
    Cancer Res; 1984 Dec; 44(12 Pt 1):5934-8. PubMed ID: 6498851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROSWELL PARK MEMORIAL INSTITUTE. THE STATE OF NEW YORK'S WORLD-FAMED CANCER CENTER.
    MILLER RW
    CA Cancer J Clin; 1964; 14():140-5. PubMed ID: 14179518
    [No Abstract]   [Full Text] [Related]  

  • 16. Production, purification and clinical application of human fibroblast interferon.
    Carter WA; Horoszewicz JS
    Pharmacol Ther; 1980; 8(2):359-77. PubMed ID: 6155675
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective studies of diet and cancer at Roswell Park Memorial Institute.
    Mettlin C
    Prog Clin Biol Res; 1990; 346():55-65. PubMed ID: 2197632
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.